Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia

Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm with variable clinical course. To predict the clinical outcome, we previously developed a CMML-specific prognostic scoring system (CPSS) based on clinical parameters and cytogenetics. In this work, we tested the...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Blood
Главные авторы: Elena, Chiara, Gallì, Anna, Such, Esperanza, Meggendorfer, Manja, Germing, Ulrich, Rizzo, Ettore, Cervera, Jose, Molteni, Elisabetta, Fasan, Annette, Schuler, Esther, Ambaglio, Ilaria, Lopez-Pavia, Maria, Zibellini, Silvia, Kuendgen, Andrea, Travaglino, Erica, Sancho-Tello, Reyes, Catricalà, Silvia, Vicente, Ana I., Haferlach, Torsten, Haferlach, Claudia, Sanz, Guillermo F., Malcovati, Luca, Cazzola, Mario
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2016
Предметы:
Myeloid Neoplasia
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5036538/
https://ncbi.nlm.nih.gov/pubmed/27385790
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2016-05-714030
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы